z-logo
open-access-imgOpen Access
Identification of a Rare BAIAP2-ROS1 Fusion and Clinical Benefit of Crizotinib in the Treatment of Advanced Lung Adenocarcinoma: A Case Report
Author(s) -
YunYu Lin,
Yan Lei,
Linwei Li,
Xiaoxing Su,
Qiqi Tian,
Wendy Wu
Publication year - 2022
Publication title -
oncotargets and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.054
H-Index - 60
ISSN - 1178-6930
DOI - 10.2147/ott.s372134
Subject(s) - crizotinib , ros1 , fusion gene , adenocarcinoma , medicine , targeted therapy , lung cancer , cancer research , cancer , computational biology , oncology , gene , biology , genetics , malignant pleural effusion

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom